Filing Details
- Accession Number:
- 0001209191-21-055480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:05:35
- Reporting Period:
- 2021-08-02
- Accepted Time:
- 2021-09-10 17:05:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-02 | 85 | $3.34 | 173,870 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-03 | 85 | $3.17 | 173,955 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-04 | 85 | $3.18 | 174,040 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-05 | 85 | $3.11 | 174,125 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-06 | 85 | $3.01 | 174,210 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-09 | 85 | $2.93 | 174,295 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-10 | 85 | $2.96 | 174,380 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-11 | 85 | $2.98 | 174,465 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-13 | 85 | $2.92 | 174,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-16 | 85 | $2.92 | 174,635 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-17 | 85 | $3.05 | 174,720 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-18 | 85 | $2.97 | 174,805 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-19 | 85 | $3.02 | 174,890 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-20 | 85 | $2.96 | 174,975 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-23 | 85 | $2.87 | 175,060 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-24 | 85 | $2.89 | 175,145 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-25 | 85 | $2.79 | 175,230 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-26 | 85 | $2.82 | 175,315 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-27 | 85 | $2.84 | 175,400 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-30 | 85 | $2.88 | 175,485 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-31 | 85 | $2.93 | 175,570 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
